Quimigen Portugal > ERCC8 Antibody - N-terminal region - FITC
ERCC8 Antibody - N-terminal region - FITC
Brand : Aviva Systems Biology
Size:100ul
Bulk
Order
Order
Aviva's
Satisfaction
Guarantee
Satisfaction
Guarantee
Contact Us:
- Toll Free: 888-880-0001
- Phone: 858-552-6979
- Email: info@avivasysbio.com
Shipping Info:
- : Antibody & Protein in US
- + /Kit in US
- Contact us for international orders.
ERCC8 Antibody - N-terminal region : FITC (ARP32149_P050-FITC)
Click here to learn more about Aviva's By-Request Conjugation Service.
| Datasheets/Manuals | Printable datasheet for anti-ERCC8 (ARP32149_P050-FITC) antibody |
|---|
| Predicted Species Reactivity | Human, Mouse, Rat, Cow, Dog, Guinea Pig, Pig, Rabbit, Zebrafish |
|---|---|
| Product Format | Liquid. Purified antibody supplied in 1x PBS buffer. |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugation | FITC: Fluorescein Isothiocyanate |
| Application | WB, IHC |
| Reconstitution and Storage | All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil). Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding. |
| Immunogen | The immunogen is a synthetic peptide directed towards the N terminal region of human ERCC8 |
| Purification | Affinity Purified |
| Predicted Homology Based on Immunogen Sequence | Cow: 77%; Dog: 85%; Guinea Pig: 77%; Human: 100%; Mouse: 85%; Pig: 85%; Rabbit: 85%; Rat: 77%; Zebrafish: 85% |
| Peptide Sequence | Synthetic peptide located within the following region: DVERIHGGGINTLDIEPVEGRYMLSGGSDGVIVLYDLENSSRQSYYTCKA |
| Concentration | 0.5 mg/ml |
| Blocking Peptide | For anti-ERCC8 (ARP32149_P050-FITC) antibody is Catalog # AAP32149 (Previous Catalog # AAPP03115) |
| Reference | Sarker,A.H., et al., (2005) Mol. Cell 20 (2), 187-198 |
|---|---|
| Gene Symbol | ERCC8 |
| Gene Full Name | Excision repair cross-complementing rodent repair deficiency, complementation group 8 |
| Alias Symbols | CSA, CKN1, UVSS2 |
| NCBI Gene Id | 1161 |
| Protein Name | DNA excision repair protein ERCC-8 |
| Description of Target | ERCC8 is a WD repeat protein, which interacts with Cockayne syndrome type B (CSB) protein and with p44 protein, a subunit of the RNA polymerase II transcription factor IIH. Mutations in this gene have been identified in patients with hereditary disease Cockayne syndrome (CS). This gene encodes a WD repeat protein, which interacts with Cockayne syndrome type B (CSB) protein and with p44 protein, a subunit of the RNA polymerase II transcription factor IIH. Mutations in this gene have been identified in patients with hereditary disease Cockayne syndrome (CS). CS cells are abnormally sensitive to ultraviolet radiation and are defective in the repair of transcriptionally active genes. |
| Uniprot ID | Q13216 |
| Protein Accession # | NP_000073 |
| Nucleotide Accession # | NM_000082 |
| Protein Size (# AA) | 396 |
| Molecular Weight | 44kDa |
| Protein Interactions | CUL4A; CUL4B; DDB1; RUVBL2; ZNF24; PCNA; H1F0; ERCC6; UVSSA; DDA1; RFWD2; COPS4; COPS6; COPS3; TOP1; TP53; SSBP1; OGG1; MDM2; GTF2H2; CUL5; GPS1; DDB2; COPS2; COPS7A; COPS5; COPS8; RBX1; POLR2A; HMGN1; EP300; UBC; CSNK2B; XAB2; UQCRQ; CBR1; |
-
ERCC8 Antibody - N-terminal region (ARP32149_P050)Catalog #: ARP32149_P050Species Tested: HumanApplication: WB, IHCFormat: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. -
ERCC8 Antibody - C-terminal region (ARP31542_P050)Catalog #: ARP31542_P050Species Tested: HumanApplication: IHC, WBFormat: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. -
ERCC8 Antibody - middle region (OAAB00976)Catalog #: OAAB00976Application: IHC-P,WBFormat: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.


